FLGT Fulgent Genetics, Inc.

Price (delayed)

$44.84

Market cap

$1.09B

P/E Ratio

20.76

Dividend/share

N/A

EPS

$2.16

Enterprise value

$1.04B

Sector: Healthcare
Industry: Diagnostics & Research
Fulgent Genetics, Inc. operates as a technology company, which provides genetic testing and next generation sequencing solutions. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

Highlights

The company's equity has surged by 115% QoQ
FLGT's gross margin is up by 24% year-on-year and by 24% since the previous quarter
FLGT's quick ratio has dropped by 67% year-on-year and by 46% since the previous quarter

Key stats

What are the main financial stats of FLGT
Market
Shares outstanding
24.27M
Market cap
$1.09B
Enterprise value
$1.04B
Valuations
Price to earnings (P/E)
20.76
Price to book (P/B)
5.24
Price to sales (P/S)
7.32
EV/EBIT
16.84
EV/EBITDA
16.1
EV/Sales
7.68
Earnings
Revenue
$135.12M
EBIT
$61.63M
EBITDA
$64.48M
Free cash flow
-$7.05M
Per share
EPS
$2.16
Free cash flow per share
-$0.32
Book value per share
$8.56
Revenue per share
$6.12
TBVPS
$11.21
Balance sheet
Total assets
$247.31M
Total liabilities
$60.36M
Debt
$2.74M
Equity
$186.96M
Working capital
$137.88M
Liquidity
Debt to equity
0.01
Current ratio
3.39
Quick ratio
2.87
Net debt/EBITDA
-0.78
Margins
EBITDA margin
47.7%
Gross margin
69.2%
Net margin
35.3%
Operating margin
47.2%
Efficiency
Return on assets
36.6%
Return on equity
43.6%
Return on invested capital
64.6%
Return on capital employed
32.5%
Return on sales
45.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FLGT stock price

How has the Fulgent Genetics stock price performed over time
Intraday
10.36%
1 week
2.84%
1 month
37.84%
1 year
293.33%
YTD
247.6%
QTD
11.99%

Financial performance

How have Fulgent Genetics's revenue and profit performed over time
Revenue
$135.12M
Gross profit
$93.45M
Operating income
$63.84M
Net income
$47.71M
Gross margin
69.2%
Net margin
35.3%
FLGT's gross margin is up by 24% year-on-year and by 24% since the previous quarter

Growth

What is Fulgent Genetics's growth rate over time

Valuation

What is Fulgent Genetics stock price valuation
P/E
20.76
P/B
5.24
P/S
7.32
EV/EBIT
16.84
EV/EBITDA
16.1
EV/Sales
7.68
The company's equity has surged by 115% QoQ
The price to book (P/B) is 81% higher than the 5-year quarterly average of 2.9 and 46% higher than the last 4 quarters average of 3.6
FLGT's P/S is 26% above its 5-year quarterly average of 5.8 and 3.1% above its last 4 quarters average of 7.1

Efficiency

How efficient is Fulgent Genetics business performance

Dividends

What is FLGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FLGT.

Financial health

How did Fulgent Genetics financials performed over time
FLGT's quick ratio has dropped by 67% year-on-year and by 46% since the previous quarter
FLGT's current ratio has dropped by 63% year-on-year and by 46% since the previous quarter
Fulgent Genetics's debt is 99% less than its equity
FLGT's debt to equity has dropped by 80% year-on-year and by 67% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.